Last week, the biotech sector was in focus, with regular pipeline and regulatory updates. Vanda Pharmaceuticals Inc. VNDA was in the spotlight after it rejected a second takeover bid by Cycle Group.

The US Food and Drug Administration (FDA) yesterday published the guidance for industry, “Requests for Reconsideration at the ...

In May, Bruce Brown paid $21 for refill of a prescription antifungal medication he's been taking for decades. Three months ...

Becoming Nancy at Birmingham Rep, directed and choroegraphed by Jerry Mitchell, held its official press night in the UK ...

The twin giant panda cubs born in Hong Kong in August this year have left their incubators and taken on distinctive features amid rapid growth said O ...

Frameplay, an in-game advertising company, is joining direct competitors to cultivate a critical mass of scale for ...

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Toni: I understand that there is a major change to the 2025 Medicare Part D plan with the “Donut Hole” going away. I’m concerned because this year, I entered the ...

Swiss generic and biosimilar medicines major Sandoz today announced that it has launched a generic paclitaxel formulation in ...

This health news roundup covers various topics including Gerresheimer's stock jump due to an activist investor, a US list of ...

Florida is making final preparations ahead of Hurricane Milton which is forecast to make landfall near Tampa Bay on the west central coast of the US ...

Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...